Literature DB >> 2744069

Stereoselective plasma protein binding of ibuprofen enantiomers.

A M Evans1, R L Nation, L N Sansom, F Bochner, A A Somogyi.   

Abstract

We have developed a novel and reproducible method for determining the plasma protein binding of the two ibuprofen enantiomers in the presence of each other. The method involves the use of radiolabelled racemic ibuprofen, equilibrium dialysis, derivatization of the enantiomers to diastereomeric amides, high-performance liquid chromatography, and radiochemical analysis. We have determined the plasma protein binding of R(-)- and S(+)-ibuprofen in 6 healthy male volunteers after the oral administration of 800 mg racemic ibuprofen. The mean time-averaged percentage unbound of the R(-)-enantiomer, 0.419 was significantly less than that of the S(+)-enantiomer, 0.643, consistent with stereoselective plasma protein binding. The percentage unbound of each ibuprofen enantiomer was concentration-dependent over the therapeutic concentration range and was influenced by the presence of its optical antipode.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744069     DOI: 10.1007/bf00558161

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

2.  High stereospecificity of the benzodiazepine binding site on human serum albumin. Studies with d- and l-oxazepam hemisuccinate.

Authors:  W E Müller; U Wollert
Journal:  Mol Pharmacol       Date:  1975-01       Impact factor: 4.436

Review 3.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

4.  Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis.

Authors:  J D Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

5.  Pharmacokinetics of ibuprofen in man--III: Plasma protein binding.

Authors:  G F Lockwood; K S Albert; G J Szpunar; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1983-10

6.  Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Protein binding of chloroquine enantiomers and desethylchloroquine.

Authors:  D Ofori-Adjei; O Ericsson; B Lindström; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

8.  Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.

Authors:  M Eichelbaum; G Mikus; B Vogelgesang
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

9.  The binding of ibuprofen to plasma proteins.

Authors:  L Aarons; D M Grennan; M Siddiqui
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.

Authors:  J M Gallo; E P Gall; W R Gillespie; K S Albert; D Perrier
Journal:  J Clin Pharmacol       Date:  1986-01       Impact factor: 3.126

View more
  25 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 3.  Stereoselectivity in clinical pharmacokinetics and drug development.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 4.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Stereoselective disposition of flurbiprofen in normal volunteers.

Authors:  M P Knadler; D C Brater; S D Hall
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 6.  Chirality. Clinical pharmacokinetic and pharmacodynamic considerations.

Authors:  E J Lee; K M Williams
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

7.  The effect of octanoic acid on the binding of the enantiomers of ibuprofen and naproxen to human serum albumin: a chromatographic implication.

Authors:  V K Cheruvallath; C M Riley; S R Narayanan; S Lindenbaum; J H Perrin
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

Review 8.  Chirality and nonsteroidal anti-inflammatory drugs.

Authors:  P J Hayball
Journal:  Drugs       Date:  1996       Impact factor: 9.546

9.  Stereoselective systemic disposition of ibuprofen enantiomers in the dog.

Authors:  H Y Ahn; G L Amidon; D E Smith
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

10.  Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.